Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gingerich, R. L.
Right arrow Articles by Johnson, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gingerich, R. L.
Right arrow Articles by Johnson, M. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 27, Issue 2 96-101, Copyright © 1978 by American Diabetes Association


ARTICLES

Regional pancreatic concentration and in-vitro secretion of canine pancreatic polypeptide, insulin, and glucagon

RL Gingerich, PE Lacy, RE Chance and MG Johnson

The regional concentrations and in-vitro secretions of canine pancreatic polypeptide (cPP), insulin, and glucagon were studied. CPP is found predominantly in the uncinate process of the dog pancreas, whereas insulin and, more markedly, glucagon predominate in the body and tail of the pancreas. In-vitro secretion studies of pancreatic pieces indicate that dibutyryl cyclic AMP (dcAMP) alone can stimulate cPP release whereas glucose and arginine alone have no effect. Arginine, but not glucose, potentiates this stimulant effect of dcAMP. These studies suggest that the cAMP generating system may play a role in regulation of cPP secretion.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. M. Arbelaez, W. J. Powers, T. O. Videen, J. L. Price, and P. E. Cryer
Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition: A Mechanism for Hypoglycemia-Associated Autonomic Failure
Diabetes, February 1, 2008; 57(2): 470 - 475.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. M. Breckenridge, B. A. Cooperberg, A. M. Arbelaez, B. W. Patterson, and P. E. Cryer
Glucagon, in Concert With Insulin, Supports the Postabsorptive Plasma Glucose Concentration in Humans
Diabetes, October 1, 2007; 56(10): 2442 - 2448.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Raju and P. E. Cryer
Loss of the Decrement in Intraislet Insulin Plausibly Explains Loss of the Glucagon Response to Hypoglycemia in Insulin-Deficient Diabetes: Documentation of the Intraislet Insulin Hypothesis in Humans
Diabetes, March 1, 2005; 54(3): 757 - 764.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Raju and P. E. Cryer
Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E80 - E85.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. A. DeRosa and P. E. Cryer
Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E32 - E41.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Teves, T. O. Videen, P. E. Cryer, and W. J. Powers
Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia
PNAS, April 20, 2004; 101(16): 6217 - 6221.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Raju, V. P. McGregor, and P. E. Cryer
Cortisol Elevations Comparable to Those That Occur During Hypoglycemia Do Not Cause Hypoglycemia-Associated Autonomic Failure
Diabetes, August 1, 2003; 52(8): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Banarer and P. E. Cryer
Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes: Reduced Awakening From Sleep During Hypoglycemia
Diabetes, May 1, 2003; 52(5): 1195 - 1203.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. P. McGregor, J. S. Greiwe, S. Banarer, and P. E. Cryer
Limited Impact of Vigorous Exercise on Defenses Against Hypoglycemia: Relevance to Hypoglycemia-Associated Autonomic Failure
Diabetes, May 1, 2002; 51(5): 1485 - 1492.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Banarer, V. P. McGregor, and P. E. Cryer
Intraislet Hyperinsulinemia Prevents the Glucagon Response to Hypoglycemia Despite an Intact Autonomic Response
Diabetes, April 1, 2002; 51(4): 958 - 965.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Segel, C. G. Fanelli, C. S. Dence, J. Markham, T. O. Videen, D. S. Paramore, W. J. Powers, and P. E. Cryer
Blood-to-Brain Glucose Transport, Cerebral Glucose Metabolism, and Cerebral Blood Flow Are Not Increased After Hypoglycemia
Diabetes, August 1, 2001; 50(8): 1911 - 1917.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. A. D’Alessio, T. J. Kieffer, G. J. Taborsky Jr., and P. J. Havel
Activation of the Parasympathetic Nervous System Is Necessary for Normal Meal-Induced Insulin Secretion in Rhesus Macaques
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1253 - 1259.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. H. Coker, Y. Koyama, D. B. Lacy, P. E. Williams, N. Rheaume, and D. H. Wasserman
Pancreatic innervation is not essential for exercise-induced changes in glucagon and insulin or glucose kinetics
Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1122 - E1129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. S. Paramore, C. G. Fanelli, S. D. Shah, and P. E. Cryer
Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E872 - E881.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Ahrén and G. Pacini
Age-Related Reduction in Glucose Elimination Is Accompanied by Reduced Glucose Effectiveness and Increased Hepatic Insulin Extraction in Man
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3350 - 3356.
[Abstract] [Full Text]


Home page
NEJMHome page
P. J. Boyle, S. F. Kempers, A. M. O'Connor, and R. J. Nagy
Brain Glucose Uptake and Unawareness of Hypoglycemia in Patients with Insulin-Dependent Diabetes Mellitus
N. Engl. J. Med., December 28, 1995; 333(26): 1726 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. P. McGregor, S. Banarer, and P. E. Cryer
Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E770 - E777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1978 by the American Diabetes Association.